As we reflect back on our 20 years, some of our key accomplishments are:

• As we reflect back on our 20 years, some of our key accomplishments are: Played a key role in the development of over 40 ophthalmic, dermatologic, and neurologic approved products
• NDA Firsts: First treatment for macular degeneration, First soft drug, First and second intravitreal drug delivery system
• Served over 350 clients in four continents on thousands of projects
• Contributed to over 100 IND and IDE submissions
• Organized and lead clients on scores of meetings with regulatory agencies worldwide
• Serving as a director of a publicly traded ophthalmic pharmaceutical firm, including raising over $100 million in financing
• Served as agent for a multi-million dollar licensing arrangement
• Created several business plans, including one funded at over $80 million
• Had our 160th paper printed in a peer-reviewed journal
• Published over 60 additional papers as medical writer, plus others as editor for non-English speakers
• Performed 100’s of literature and patent searches, including support for patent arbitration